ODAN-SPOR 1.75 MG — DIN 00635065
NEOMYCIN (NEOMYCIN SULFATE) : 1.75 MG GRAMICIDIN : .025 MG POLYMYXIN B SULFATE : 10000 UNIT · ODAN LABORATORIES LTD · LIQUID · wholesale supply in Canada
Health Canada status: DORMANT
What is ODAN-SPOR?
ODAN-SPOR 1.75 MG contains NEOMYCIN (NEOMYCIN SULFATE) : 1.75 MG GRAMICIDIN : .025 MG POLYMYXIN B SULFATE : 10000 UNIT. It is listed in the Health Canada Drug Product Database under DIN 00635065, held by ODAN LABORATORIES LTD, supplied as LIQUID for OPHTHALMIC administration. Health Canada currently lists it as dormant, status dated 22-Jun-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A). This DIN is not currently being marketed in Canada, so it is sourced to order where a compliant route exists rather than held in stock.
What is ODAN-SPOR used for?
ODAN-SPOR is used for the prophylaxis and treatment of eye infections. To reduce the development of drug-resistant bacteria and maintain the effectiveness of ODAN-SPOR and other antibacterial drugs, ODAN-SPOR should be used only to treat infections that are proven or strongly suspected to be caused by bacteria.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Combinations Of Different Antibiotics cost around the world?
Combinations Of Different Antibiotics is listed on 4 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Czechia publishes a max producer price (ex-factory); Hungary publishes a producer price (ex-factory); Iceland publishes a max wholesale. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Hungary | producer price (ex-factory) | 5 | 5 | HUF███.██ |
| Czechia | max producer price (ex-factory) | 1 | 1 | CZK███.██ |
| Iceland | max wholesale | 1 | 1 | ISK███.██ |
| Luxembourg | reimbursement | 1 | 1 | EUR███.██ |
8 pack listings across 8 brand entries and 4 price bases, refreshed 05 Sep 2026. Ranges span every Combinations Of Different Antibiotics pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Combinations Of Different Antibiotics in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
11 holders have a Canadian DIN containing Combinations Of Different Antibiotics, across 14 DINs, of which 2 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| STERI-MED PHARMA INC. | 3 | 1 | DIOSPORIN OINTMENT, PINK EYE OINTMENT, STERISPORIN | Sourceable in Canada |
| SANDOZ CANADA INCORPORATED | 1 | 1 | SANDOZ POLYTRIMETHOPRIM | Sourceable in Canada |
| EURO-PHARM INTERNATIONAL CANADA INC | 2 | 0 | EUROSPORIN, OPTIMYXIN OPHTHALMIC OINTMENT | No marketed DIN |
| ALLERGAN INC | 1 | 0 | POLYTRIM OPHTHALMIC SOLUTION | No marketed DIN |
| GLAXO WELLCOME INC. | 1 | 0 | POLYSPORIN STERILE OPHTHALMIC OINTMENT | No marketed DIN |
| GLAXOSMITHKLINE INC | 1 | 0 | NEOSPORIN OPHTHALMIC OINTMENT | No marketed DIN |
| JOHNSON & JOHNSON INC | 1 | 0 | POLYSPORIN STERILE OPHTHALMIC OINTMENT | No marketed DIN |
| NOVARTIS OPHTHALMICS NOVARTIS PHARMACEUTICALS (CANADA) INC | 1 | 0 | POLYCIDIN OPHTHALMIC OINTMENT | No marketed DIN |
| ODAN LABORATORIES LTD | 1 | 0 | ODAN-SPOR | No marketed DIN |
| PHARMASCIENCE INC | 1 | 0 | PMS-POLYTRIMETHOPRIM | No marketed DIN |
| PHARMAVITE LABORATORIES (1987) INC. | 1 | 0 | NEO BACE OPHTHALMIC OINTMENT | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 1.75 MG |
|---|---|
| Dosage form | LIQUID |
| Route | OPHTHALMIC |
| Pack configuration (monograph) | 10 mL sterile solution in plastic bottles with applicator tip, individually packaged |
| Storage | Store between 15°C and 30°C and protect from light. |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Combinations Of Different Antibiotics |
|---|---|
| ATC code | S01AA30 |
| AHFS class | 52:04.04 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 00635065 |
|---|---|
| DIN (unpadded, as printed on some documents) | 635065 |
| Brand name | ODAN-SPOR |
| Generic / active ingredient | NEOMYCIN (NEOMYCIN SULFATE) : 1.75 MG GRAMICIDIN : .025 MG POLYMYXIN B SULFATE : 10000 UNIT |
| Market authorization holder | ODAN LABORATORIES LTD |
| Health Canada schedule | Prescription |
| ATC code | S01AA30 |
| ATC anatomical main group | S — Sensory organs |
| ATC therapeutic subgroup | S01AA |
| Current status | DORMANT |
| Status date | 22-Jun-2017 |
| Original market date | 1992-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
2 of 14 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| SANDOZ POLYTRIMETHOPRIM | 10000 UNIT | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | 02239234 |
| STERISPORIN | 10000 UNIT | OINTMENT | STERI-MED PHARMA INC. | MARKETED | 02359928 |
| DIOSPORIN OINTMENT | 10000 UNIT | OINTMENT | STERI-MED PHARMA INC. | DORMANT | 02023792 |
| EUROSPORIN | 10000 UNIT | OINTMENT | EURO-PHARM INTERNATIONAL CANADA INC | CANCELLED PRE MARKET | 02466848 |
| NEO BACE OPHTHALMIC OINTMENT | 5000 UNIT | OINTMENT | PHARMAVITE LABORATORIES (1987) INC. | CANCELLED POST MARKET | 00221392 |
| NEOSPORIN OPHTHALMIC OINTMENT | 10000 UNIT | OINTMENT | GLAXOSMITHKLINE INC | CANCELLED POST MARKET | 00694398 |
| OPTIMYXIN OPHTHALMIC OINTMENT | 500 UNIT | OINTMENT | EURO-PHARM INTERNATIONAL CANADA INC | DORMANT | 02160889 |
| PINK EYE OINTMENT | 10000 UNIT | OINTMENT | STERI-MED PHARMA INC. | APPROVED | 02523507 |
| PMS-POLYTRIMETHOPRIM | 1 MG | LIQUID | PHARMASCIENCE INC | CANCELLED POST MARKET | 02240363 |
| POLYCIDIN OPHTHALMIC OINTMENT | 10000 UNIT | OINTMENT | NOVARTIS OPHTHALMICS NOVARTIS PHARMACEUTICALS (CANADA) INC | CANCELLED POST MARKET | 02230193 |
2 · Same class — other molecules in ATC S01AA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Erythromycin | ERYMYCIN OPHTHALMIC OINTMENT 5MG/G · ERYTHROMYCIN · ERYTHROMYCIN OPHTHALMIC OINTMENT U.S.P. · ERYTHROMYCIN OPHTHALMIC OINTMENT USP · +5 more | 9 | 3 | Yes |
| Tobramycin | APO-TOBRAMYCIN · PMS-TOBRAMYCIN 0.3% OPHTHALMIC SOLUTION · SANDOZ TOBRAMYCIN · TOBRAMYCIN OPHTHALMIC SOLUTION USP 0.3% · +2 more | 7 | 3 | Yes |
| Combinations Of Different Antibiotics | DIOSPORIN OINTMENT · EUROSPORIN · NEO BACE OPHTHALMIC OINTMENT · NEOSPORIN OPHTHALMIC OINTMENT · +9 more | 14 | 2 | Yes |
| Fusidic Acid | FUCITHALMIC | 2 | 1 | Yes |
| Gentamicin | ALCOMICIN OPH SOL 3MG/ML · GARAMYCIN OPHTHALMIC DROPS 0.3% · GARAMYCIN OPHTHALMIC OINTMENT 0.3% · GARATEC OPHTHALMIC DPS 5MG/ML · +14 more | 22 | 0 | Not in Canada |
| Chloramphenicol | CEBENICOL OPH LIQ 0.4% · CHLORAMPHENICOL · CHLOROMYCETIN OPH ONT 1% · CHLOROMYCETIN OPH SOLN 0.5% · +12 more | 18 | 0 | Not in Canada |
| Framycetin | SOFRAMYCIN EYE DROPS · SOFRAMYCIN EYE DROPS 0.5% · SOFRAMYCIN EYE DROPS 5MG/ML · SOFRAMYCIN EYE ONT 0.5% · +2 more | 6 | 0 | Not in Canada |
| Tetracycline | ACHROMYCIN ONT OPH 1% · TETRACYCLINE 1% OPHTHALMIC OINTMENT | 2 | 0 | Not in Canada |
| Azithromycin | AZASITE | 2 | 0 | Not in Canada |
| Bacitracin | BACIGUENT OPH ONT 500UNIT/GM | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC S01A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| S01AE | Besifloxacin · Ciprofloxacin · Gatifloxacin · Moxifloxacin · Ofloxacin | 25 | 12 |
| S01AD | Ganciclovir · Idoxuridine · Trifluridine | 6 | 1 |
| S01AB | Sulfacetamide · Sulfacetamide, Combinations | 14 | 0 |
| S01AX | Norfloxacin · Sodium Borate | 15 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is ODAN-SPOR called?
The same molecule, Combinations Of Different Antibiotics, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Ekyflogyl | Latin | Iceland |
| OTIPAX | Latin | Czechia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
This DIN is dormant — it holds a Health Canada authorization but is not currently being marketed in Canada, so it cannot simply be ordered from Canadian stock. Where a patient need exists, supply may be possible through exceptional importation or the Special Access Programme, subject to Health Canada's requirements and the prescriber's application. Nexara can advise on the route and on marketed alternatives.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.